Interestingly, a previous study has reported that by using a combination of proteins (complement component 4a (C4a) and protein C inhibitor), a statistically significant value for predicting prostate cancer recurrence was demonstrated in men who underwent prostatectomy [51]. The gene discussed is C4A; the disease is prostate cancer.